Everolimus in patients with autosomal dominant polycystic kidney disease

Autosomal dominant polycystic kidney disease (ADPKD) affects approximately 1 of every 1000 persons in the general population1 and develops, by means of slowly progressive renal-cyst growth, to end-stage renal disease in over 50% of patients. Hepatic and pancreatic cysts, as well as cerebral and abdo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Walz, Gerd (VerfasserIn) , Budde, Klemens (VerfasserIn) , Mannaa, Marwan (VerfasserIn) , Nürnberger, Jens (VerfasserIn) , Wanner, Christoph (VerfasserIn) , Sommerer, Claudia (VerfasserIn) , Kunzendorf, Ulrich (VerfasserIn) , Banas, Bernhard (VerfasserIn) , Hörl, Walter H. (VerfasserIn) , Obermüller, Nicholas (VerfasserIn) , Arns, Wolfgang (VerfasserIn) , Pavenstädt, Hermann (VerfasserIn) , Gaedeke, Jens (VerfasserIn) , Büchert, Martin (VerfasserIn) , May, Christoph (VerfasserIn) , Gschaidmeier, Harald (VerfasserIn) , Kramer, Stefan (VerfasserIn) , Eckardt, Kai-Uwe (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: June 26, 2010
In: The New England journal of medicine
Year: 2010, Jahrgang: 363, Heft: 9, Pages: 830-840
ISSN:1533-4406
DOI:10.1056/NEJMoa1003491
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1056/NEJMoa1003491
Verlag, lizenzpflichtig, Volltext: https://www.nejm.org/doi/full/10.1056/NEJMoa1003491
Volltext
Verfasserangaben:Gerd Walz, Klemens Budde, Marwan Mannaa, Jens Nürnberger, Christoph Wanner, Claudia Sommerer, Ulrich Kunzendorf, Bernhard Banas, Walter H. Hörl, Nicholas Obermüller, Wolfgang Arns, Hermann Pavenstädt, Jens Gaedeke, Martin Büchert, Christoph May, Harald Gschaidmeier, Stefan Kramer, and Kai-Uwe Eckardt

MARC

LEADER 00000caa a2200000 c 4500
001 1861116810
003 DE-627
005 20240311123352.0
007 cr uuu---uuuuu
008 231010s2010 xx |||||o 00| ||eng c
024 7 |a 10.1056/NEJMoa1003491  |2 doi 
035 |a (DE-627)1861116810 
035 |a (DE-599)KXP1861116810 
035 |a (OCoLC)1425873613 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Walz, Gerd  |d 1957-  |e VerfasserIn  |0 (DE-588)111077415X  |0 (DE-627)865160295  |0 (DE-576)47577373X  |4 aut 
245 1 0 |a Everolimus in patients with autosomal dominant polycystic kidney disease  |c Gerd Walz, Klemens Budde, Marwan Mannaa, Jens Nürnberger, Christoph Wanner, Claudia Sommerer, Ulrich Kunzendorf, Bernhard Banas, Walter H. Hörl, Nicholas Obermüller, Wolfgang Arns, Hermann Pavenstädt, Jens Gaedeke, Martin Büchert, Christoph May, Harald Gschaidmeier, Stefan Kramer, and Kai-Uwe Eckardt 
264 1 |c June 26, 2010 
300 |b Diagramme 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 10.10.2023 
520 |a Autosomal dominant polycystic kidney disease (ADPKD) affects approximately 1 of every 1000 persons in the general population1 and develops, by means of slowly progressive renal-cyst growth, to end-stage renal disease in over 50% of patients. Hepatic and pancreatic cysts, as well as cerebral and abdominal aneurysms, contribute to ADPKD-associated morbidity and mortality. Arterial hypertension, recurrent urinary tract infection, nephrolithiasis, and abdominal pain are frequently the presenting symptoms.2 Approximately 85% of patients with ADPKD have mutations in the polycystic kidney disease 1 gene (PKD1), whereas most of the remaining 15% have polycystic kidney disease 2 gene (PKD2) . . . 
700 1 |a Budde, Klemens  |e VerfasserIn  |4 aut 
700 1 |a Mannaa, Marwan  |e VerfasserIn  |4 aut 
700 1 |a Nürnberger, Jens  |e VerfasserIn  |4 aut 
700 1 |a Wanner, Christoph  |e VerfasserIn  |4 aut 
700 1 |a Sommerer, Claudia  |d 1971-  |e VerfasserIn  |0 (DE-588)121857654  |0 (DE-627)705680002  |0 (DE-576)292921829  |4 aut 
700 1 |a Kunzendorf, Ulrich  |e VerfasserIn  |4 aut 
700 1 |a Banas, Bernhard  |e VerfasserIn  |4 aut 
700 1 |a Hörl, Walter H.  |e VerfasserIn  |4 aut 
700 1 |a Obermüller, Nicholas  |e VerfasserIn  |4 aut 
700 1 |a Arns, Wolfgang  |e VerfasserIn  |4 aut 
700 1 |a Pavenstädt, Hermann  |e VerfasserIn  |4 aut 
700 1 |a Gaedeke, Jens  |e VerfasserIn  |4 aut 
700 1 |a Büchert, Martin  |e VerfasserIn  |4 aut 
700 1 |a May, Christoph  |e VerfasserIn  |4 aut 
700 1 |a Gschaidmeier, Harald  |e VerfasserIn  |4 aut 
700 1 |a Kramer, Stefan  |e VerfasserIn  |4 aut 
700 1 |a Eckardt, Kai-Uwe  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t The New England journal of medicine  |d Waltham, Mass. : MMS, 1928  |g 363(2010), 9, Seite 830-840  |h Online-Ressource  |w (DE-627)266889484  |w (DE-600)1468837-2  |w (DE-576)075962454  |x 1533-4406  |7 nnas  |a Everolimus in patients with autosomal dominant polycystic kidney disease 
773 1 8 |g volume:363  |g year:2010  |g number:9  |g pages:830-840  |g extent:11  |a Everolimus in patients with autosomal dominant polycystic kidney disease 
856 4 0 |u https://doi.org/10.1056/NEJMoa1003491  |x Resolving-System  |x Verlag  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nejm.org/doi/full/10.1056/NEJMoa1003491  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20231010 
993 |a Article 
994 |a 2010 
998 |g 121857654  |a Sommerer, Claudia  |m 121857654:Sommerer, Claudia  |d 50000  |e 50000PS121857654  |k 0/50000/  |p 6 
999 |a KXP-PPN1861116810  |e 4383152279 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"given":"Gerd","role":"aut","family":"Walz","display":"Walz, Gerd"},{"display":"Budde, Klemens","family":"Budde","given":"Klemens","role":"aut"},{"given":"Marwan","role":"aut","family":"Mannaa","display":"Mannaa, Marwan"},{"role":"aut","given":"Jens","family":"Nürnberger","display":"Nürnberger, Jens"},{"display":"Wanner, Christoph","family":"Wanner","given":"Christoph","role":"aut"},{"display":"Sommerer, Claudia","family":"Sommerer","role":"aut","given":"Claudia"},{"display":"Kunzendorf, Ulrich","family":"Kunzendorf","given":"Ulrich","role":"aut"},{"display":"Banas, Bernhard","family":"Banas","role":"aut","given":"Bernhard"},{"display":"Hörl, Walter H.","family":"Hörl","given":"Walter H.","role":"aut"},{"role":"aut","given":"Nicholas","display":"Obermüller, Nicholas","family":"Obermüller"},{"role":"aut","given":"Wolfgang","display":"Arns, Wolfgang","family":"Arns"},{"given":"Hermann","role":"aut","display":"Pavenstädt, Hermann","family":"Pavenstädt"},{"given":"Jens","role":"aut","display":"Gaedeke, Jens","family":"Gaedeke"},{"display":"Büchert, Martin","family":"Büchert","role":"aut","given":"Martin"},{"display":"May, Christoph","family":"May","given":"Christoph","role":"aut"},{"role":"aut","given":"Harald","family":"Gschaidmeier","display":"Gschaidmeier, Harald"},{"role":"aut","given":"Stefan","display":"Kramer, Stefan","family":"Kramer"},{"role":"aut","given":"Kai-Uwe","display":"Eckardt, Kai-Uwe","family":"Eckardt"}],"title":[{"title_sort":"Everolimus in patients with autosomal dominant polycystic kidney disease","title":"Everolimus in patients with autosomal dominant polycystic kidney disease"}],"note":["Gesehen am 10.10.2023"],"origin":[{"dateIssuedDisp":"June 26, 2010","dateIssuedKey":"2010"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"name":{"displayForm":["Gerd Walz, Klemens Budde, Marwan Mannaa, Jens Nürnberger, Christoph Wanner, Claudia Sommerer, Ulrich Kunzendorf, Bernhard Banas, Walter H. Hörl, Nicholas Obermüller, Wolfgang Arns, Hermann Pavenstädt, Jens Gaedeke, Martin Büchert, Christoph May, Harald Gschaidmeier, Stefan Kramer, and Kai-Uwe Eckardt"]},"physDesc":[{"noteIll":"Diagramme","extent":"11 S."}],"recId":"1861116810","relHost":[{"id":{"eki":["266889484"],"issn":["1533-4406"],"zdb":["1468837-2"]},"pubHistory":["198.1928 -"],"recId":"266889484","name":{"displayForm":["Massachusetts Medical Society"]},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"note":["Gesehen am 04.08.25"],"origin":[{"dateIssuedKey":"1928","publisher":"MMS ; MMS","dateIssuedDisp":"1928-","publisherPlace":"Waltham, Mass. ; Boston, Mass."}],"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"NEJM"}],"title":[{"title":"The New England journal of medicine","subtitle":"NEJM","title_sort":"New England journal of medicine"}],"part":{"issue":"9","text":"363(2010), 9, Seite 830-840","pages":"830-840","year":"2010","volume":"363","extent":"11"},"corporate":[{"display":"Massachusetts Medical Society","role":"isb"}],"disp":"Everolimus in patients with autosomal dominant polycystic kidney diseaseThe New England journal of medicine"}],"id":{"eki":["1861116810"],"doi":["10.1056/NEJMoa1003491"]}} 
SRT |a WALZGERDBUEVEROLIMUS2620